DX2S:XETRA:XETRA-Xtrackers - S&P ASX 200 UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 37.45

Change

0.00 (0.00)%

Market Cap

USD 0.09B

Volume

1.25K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-01 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JARI:XETRA Amundi Index Solutions - Amund..

+0.50 (+1.13%)

USD 100.65B
EUNL:XETRA iShares Core MSCI World UCITS ..

+2.29 (+2.45%)

USD 84.07B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

+0.27 (+1.16%)

USD 79.79B
AW15:XETRA UBS (Irl) ETF plc - MSCI Japan..

+0.24 (+1.83%)

USD 58.88B
FJPR:XETRA Fidelity Sustainable Research ..

+0.03 (+0.54%)

USD 44.90B
EXX7:XETRA iShares Nikkei 225 UCITS ETF (..

+0.35 (+1.57%)

USD 28.25B
SPYL:XETRA SPDR S&P 500 UCITS ETF USD Acc..

+0.34 (+2.84%)

USD 23.49B
PPFB:XETRA iShares Physical Gold ETC EUR

-1.13 (-1.99%)

USD 20.66B
XDEE:XETRA Xtrackers S&P 500 Equal Weight..

+0.20 (+2.06%)

USD 12.74B
EUN5:XETRA iShares Core Corporate Bond UC..

-0.13 (-0.10%)

USD 12.26B

ETFs Containing DX2S:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -7.21% 34% F 33% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -7.21% 37% F 35% F
Trailing 12 Months  
Capital Gain -1.69% 26% F 32% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -1.69% 29% F 34% F
Trailing 5 Years  
Capital Gain 40.21% 47% F 51% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 40.21% 49% F 50% F
Average Annual (5 Year Horizon)  
Capital Gain 6.11% 50% F 51% F
Dividend Return 7.92% 56% F 55% F
Total Return 1.81% 88% B+ 68% D+
Risk Return Profile  
Volatility (Standard Deviation) 11.47% 54% F 63% D
Risk Adjusted Return 69.04% 60% D- 65% D
Market Capitalization 0.09B 38% F 28% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.